Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Serenity Bioworks

Serenity Bioworks?uq=8lCq2teR
2017 FOUNDED
PRIVATE STATUS
Accelerator/Inc LATEST DEAL TYPE
$250K LATEST DEAL AMOUNT
3 INVESTORS
Description

Developer of gene therapies designed to analyze genes. The company's gene therapies are the parameters to treat hemophilia, inherited retinal diseases and neurodegenerative diseases, enabling doctors to enhance the long-term efficacy and safety profiles for gene therapy which resulting in safe and longer-lasting treatments for hemophilia A.

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Other Healthcare Services
Primary Office
  • 151 Charles Street West
  • Suite 199
  • Kitchener, Ontario N2G 1H6
  • Canada
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Serenity Bioworks’s full profile, request a free trial.

Serenity Bioworks Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Accelerator/Incubator 25-Jul-2018 $250K 00000 00.000 Completed Startup
2. Accelerator/Incubator 17-Jun-2017 0000 0000 Completed Startup
1. Accelerator/Incubator 05-Apr-2017 $26.1K Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Serenity Bioworks Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
IndieBio Accelerator/Incubator Minority 000 0000 000000 0
The Accelerator Centre Accelerator/Incubator Minority 000 0000 000000 0
University of Waterloo Velocity Accelerator/Incubator 000 0000 000000 0

Serenity Bioworks Executive Team (2)

Name Title Board
Seat
Contact
Info
Cody Shirriff Co-Founder & Chief Executive Officer
Spencer Berg Co-Founder